[125] During suppressive therapy, recurrent BV occurred in 13 women (25.5%) receiving metronidazole and in 26 (59.1%) receiving placebo (RR: 0.43; 95% CI: 0.25–0.73%; p = 0.001). During the ...

Therapy of BV typically involves treatment with oral or intravaginal metronidazole or clindamycin and is associated with particularly high relapse rates. Alternative treatment options ...